MEREO BIOPHARMA GROUP PL-ADR (MREO)

US5894921072 - ADR

3.27  +0.1 (+3.15%)

After market: 3.17 -0.1 (-3.06%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
7.13M0.0036.46M0.000.00
Cost Of Goods
1.87M-940.00K17.91MN/AN/A
Gross Profit
5.26M940.00K18.56MN/AN/A
Operating Expenses
36.92M44.51M39.49M37.57M39.52M
Research and Development
19.54M24.96M23.56M16.35M23.61M
Selling, General, and Administrative Expenses
20.25M19.54M15.93M21.22M15.91M
Operating Income
-31.67M-43.57M-20.94M-37.57M-39.52M
Interest Income/Expense
4.26M7.16M35.31M-117.85M-2.87M
Other Income/Expense
-728.00K320.00K-250.00K-160.00K240.00K
Non Recurring Items
N/AN/A0.000.001.04M
Income Before Taxes
-28.14M-36.09M14.24M-166.45M-41.12M
Income Tax
-2.07M-1.90M1.52M-2.82M-6.27M
Net Income
-26.07M-34.20M12.73M-163.63M-34.84M
EBITDA
-30.97M-42.84M-20.30M-35.97M-37.94M
 
Per Share Data
EPS Diluted Total Ops
-0.19-0.270.09-2.15-1.74
 
Statistics
Gross Profit Margin
73.75%N/A50.91%N/AN/A
Profit Margin
-365.71%N/A34.91%N/AN/A
Operating Profit Margin
-444.28%N/A-57.43%N/AN/A

All data in GBP

Charts